Chargement en cours...

Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias

T315I(+) Philadelphia chromosome–positive leukemias are inherently resistant to all licensed tyrosine kinase inhibitors, and therapeutic options remain limited. We report the outcome of allogeneic stem cell transplantation in 64 patients with documented BCR-ABL(T315I) mutations. Median follow-up was...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood
Auteurs principaux: Nicolini, Franck Emmanuel, Basak, Grzegorz W., Soverini, Simona, Martinelli, Giovanni, Mauro, Michael J., Müller, Martin C., Hochhaus, Andreas, Chuah, Charles, Dufva, Inge H., Rege-Cambrin, Giovanna, Saglio, Giuseppe, Michallet, Mauricette, Labussière, Hélène, Morisset, Stéphane, Hayette, Sandrine, Etienne, Gabriel, Olavarria, Eduardo, Zhou, Wei, Peter, Senaka, Apperley, Jane F., Cortes, Jorge
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2011
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4916555/
https://ncbi.nlm.nih.gov/pubmed/21926354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-07-367326
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!